American Healthcare REIT, Inc. (NYSE:AHR – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,750,000 shares, an increase of 54.6% from the August 31st total of 3,720,000 shares. Currently, 3.4% of the shares of the company are sold short. Based on an average daily volume of 1,470,000 shares, the days-to-cover ratio is presently 3.9 days. Based on an average daily volume of 1,470,000 shares, the days-to-cover ratio is presently 3.9 days. Currently, 3.4% of the shares of the company are sold short.
American Healthcare REIT Stock Performance
Shares of AHR stock opened at $40.17 on Thursday. The stock has a fifty day moving average of $41.62 and a 200 day moving average of $36.53. American Healthcare REIT has a 52 week low of $23.66 and a 52 week high of $43.52. The firm has a market capitalization of $6.77 billion, a price-to-earnings ratio of -182.59, a PEG ratio of 2.11 and a beta of 0.98. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.41.
American Healthcare REIT (NYSE:AHR – Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The company had revenue of $542.50 million during the quarter, compared to analyst estimates of $539.49 million. During the same quarter last year, the firm posted $0.33 earnings per share. The firm’s revenue was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, research analysts expect that American Healthcare REIT will post 1.41 earnings per share for the current year.
American Healthcare REIT Dividend Announcement
Insider Buying and Selling
In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the sale, the executive vice president directly owned 59,100 shares of the company’s stock, valued at $2,475,699. This represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.92% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On American Healthcare REIT
A number of institutional investors have recently added to or reduced their stakes in the company. Sheets Smith Investment Management bought a new position in American Healthcare REIT in the third quarter worth $648,000. Cambridge Financial Group LLC purchased a new position in shares of American Healthcare REIT in the 3rd quarter worth about $504,000. GAMMA Investing LLC raised its position in shares of American Healthcare REIT by 19.6% in the 3rd quarter. GAMMA Investing LLC now owns 2,053 shares of the company’s stock worth $86,000 after purchasing an additional 337 shares during the last quarter. Corient Private Wealth LLC raised its position in shares of American Healthcare REIT by 10.9% in the 2nd quarter. Corient Private Wealth LLC now owns 8,909 shares of the company’s stock worth $327,000 after purchasing an additional 876 shares during the last quarter. Finally, Total Investment Management Inc. purchased a new position in shares of American Healthcare REIT in the 2nd quarter worth about $32,000. Institutional investors own 16.68% of the company’s stock.
Analyst Upgrades and Downgrades
AHR has been the topic of several research analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of American Healthcare REIT in a research report on Wednesday. JMP Securities increased their price objective on American Healthcare REIT from $40.00 to $45.00 and gave the company a “market outperform” rating in a research note on Monday, August 11th. KeyCorp increased their price objective on American Healthcare REIT from $34.00 to $40.00 and gave the company an “overweight” rating in a research note on Wednesday, June 11th. Robert W. Baird began coverage on American Healthcare REIT in a research note on Friday, July 18th. They set an “outperform” rating and a $41.00 price objective for the company. Finally, UBS Group began coverage on American Healthcare REIT in a research note on Friday, September 19th. They set a “buy” rating and a $51.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, American Healthcare REIT currently has an average rating of “Buy” and an average price target of $44.11.
Read Our Latest Report on American Healthcare REIT
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Read More
- Five stocks we like better than American Healthcare REIT
- Are Penny Stocks a Good Fit for Your Portfolio?
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- 3 Warren Buffett Stocks to Buy Now
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- Election Stocks: How Elections Affect the Stock Market
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.